BioCardia (BCDA) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChartTranscripts

BioCardia Revenue Highlights


Latest Revenue (Y)

$477.00K

Latest Revenue (Q)

$55.00K

Main Segment (Y)

License

Main Geography (Y)

License

BioCardia Revenue by Period


BioCardia Revenue by Year

DateRevenueChange
2023-12-31$477.00K-64.72%
2022-12-31$1.35M33.20%
2021-12-31$1.01M600.00%
2020-12-31$145.00K-79.58%
2019-12-31$710.00K13.60%
2018-12-31$625.00K30.48%
2017-12-31$479.00K-16.84%
2016-12-31$576.00K11.41%
2015-12-31$517.00K21.08%
2014-12-31$427.00K59.33%
2013-12-31$268.00K332.26%
2012-12-31$62.00K416.67%
2011-12-31$12.00K100.00%
2010-12-31--100.00%
2009-12-31$1.87M47.40%
2008-12-31$1.27M100.00%
2007-06-30-100.00%
2006-06-30-100.00%
2005-06-30--100.00%
2004-06-30$3.76M-7.82%
2003-06-30$4.08M3.06%
2002-06-30$3.96M2.35%
2001-06-30$3.87M-3.06%
2000-06-30$3.99M-5.05%
1999-06-30$4.20M10.53%
1998-06-30$3.80M11.76%
1997-06-30$3.40M8.01%
1996-06-30$3.15M-

BioCardia generated $477.00K in revenue during NA 2023, up -64.72% compared to the previous quarter, and up 76.32% compared to the same period a year ago.

BioCardia Revenue by Quarter

DateRevenueChange
2024-03-31$55.00K323.08%
2023-12-31$13.00K-96.36%
2023-09-30$357.00K730.23%
2023-06-30$43.00K-32.81%
2023-03-31$64.00K-39.62%
2022-12-31$106.00K-50.00%
2022-09-30$212.00K-78.23%
2022-06-30$974.00K1523.33%
2022-03-31$60.00K-24.05%
2021-12-31$79.00K-90.38%
2021-09-30$821.00K1089.86%
2021-06-30$69.00K50.00%
2021-03-31$46.00K-
2020-12-31$46.00K35.29%
2020-09-30$34.00K25.93%
2020-06-30$27.00K-28.95%
2020-03-31$38.00K-82.33%
2019-12-31$215.00K10.82%
2019-09-30$194.00K125.58%
2019-06-30$86.00K-60.19%
2019-03-31$216.00K109.71%
2018-12-31$103.00K22.62%
2018-09-30$84.00K-64.85%
2018-06-30$239.00K20.10%
2018-03-31$199.00K99.00%
2017-12-31$100.00K-23.08%
2017-09-30$130.00K16.07%
2017-06-30$112.00K-18.25%
2017-03-31$137.00K-102.63%
2016-12-31$-5.21M-194.82%
2016-09-30$5.50M3773.24%
2016-06-30$142.00K-4.70%
2016-03-31$149.00K10.37%
2015-12-31$135.00K11.57%
2015-09-30$121.00K-3.20%
2015-06-30$125.00K-8.09%
2015-03-31$136.00K6.25%
2014-12-31$128.00K33.33%
2014-09-30$96.00K-8.57%
2014-06-30$105.00K7.14%
2014-03-31$98.00K8.89%
2013-12-31$90.00K26.76%
2013-09-30$71.00K2.90%
2013-06-30$69.00K81.58%
2013-03-31$38.00K153.33%
2012-12-31$15.00K-21.05%
2012-09-30$19.00K11.76%
2012-06-30$17.00K54.55%
2012-03-31$11.00K-8.33%
2011-12-31$12.00K100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31--100.00%
2010-12-31$-2.75M-456.68%
2010-09-30$771.00K-28.41%
2010-06-30$1.08M19.40%
2010-03-31$902.00K62.52%
2009-12-31$555.00K27.29%
2009-09-30$436.00K-2.24%
2009-06-30$446.00K3.24%
2009-03-31$432.00K28.57%
2008-12-31$336.00K-18.25%
2008-09-30$411.00K100.00%
2008-06-30-100.00%
2008-03-31--

BioCardia generated $55.00K in revenue during Q1 2024, up 323.08% compared to the previous quarter, and up 51.89% compared to the same period a year ago.

BioCardia Revenue Breakdown


BioCardia Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 20Dec 19
Service$183.00K$191.00K
License$500.00K$500.00K

BioCardia's latest annual revenue breakdown by segment (product or service), as of Dec 20: License (73.21%), and Service (26.79%).

BioCardia Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 20Dec 19
License$500.00K$500.00K
Service$183.00K$191.00K

BioCardia's latest annual revenue breakdown by geography, as of Dec 20: License (73.21%), and Service (26.79%).

BioCardia Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
ADAGAdagene$18.11M$833.34K
BCDABioCardia$477.00K$55.00K
ABVCABVC BioPharma$152.43K$117.14K
ANEBAnebulo Pharmaceuticals--
RZLTRezolute--
FBRXForte Biosciences--
ANTXAN2 Therapeutics--
AVTEAerovate Therapeutics--
ERASErasca--
ACRVAcrivon Therapeutics--
MLYSMineralys Therapeutics--
PTIXProtagenic Therapeutics--
INDPIndaptus Therapeutics--
KTTAPasithea Therapeutics--

BCDA Revenue FAQ


BioCardia's yearly revenue for 2023 was $477K, representing a decrease of -64.72% compared to 2022. The company's yearly revenue for 2022 was $1.35M, representing an increase of 33.20% compared to 2021. BCDA's yearly revenue for 2021 was $1.02M, representing an increase of 600.00% compared to 2020.

BioCardia's quarterly revenue for Q1 2024 was $55K, a 323.08% increase from the previous quarter (Q4 2023), and a -14.06% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $13K, a -96.36% decrease from the previous quarter (Q3 2023), and a -87.74% decrease year-over-year (Q4 2022). BCDA's quarterly revenue for Q3 2023 was $357K, a 730.23% increase from the previous quarter (Q2 2023), and a 68.40% increase year-over-year (Q3 2022).

BioCardia's revenue growth rate for the last 3 years (2021-2023) was -53.00%, and for the last 5 years (2019-2023) was -32.82%.

BioCardia's revenue streams in c 20 are Service, and License. Service generated $183K in revenue, accounting 26.79% of the company's total revenue, down -4.19% year-over-year. License generated $500K in revenue, accounting 73.21% of the company's total revenue

For the fiscal year ending Dec 20, the largest source of revenue of BioCardia was License. This segment made a revenue of $500K, representing 73.21% of the company's total revenue.